USPTO serial 88836920
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jerald L. Meyer
Jerald L. Meyer NATH, GOLDBERG & MEYER112 S. WEST STREETALEXANDRIA, VA 22314UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Biochips for research or scientific purposes; next-generation sequencing bioinformatics data processor; Downloadable computer software programs for analyzing, storing, querying and computing biological sequence data, for use in the fields of bioinformatics and biotechnologies; downloadable computer application software, namely, software that provides information and advice relating to genetics, DNA screening and DNA analysis; Downloadable computer software platform for genome sequence analysis; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics; laboratory apparatus for sequencing of genomic DNA, namely, computers and computer servers that utilize downloadable software and databases; apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, automated instruments for detecting the presence, properties and identity of analytes, comprising cartridges, microarrays, silicon chip based arrays, ASICs (application specific integrated circuits), and networked computer hardware and downloadable and recorded software for performing and controlling the analysis, and for processing, displaying and storing the information obtained from the analysis for scientific or research purposes; portable apparatus and instruments for biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis, namely, microarrays, and silicon chip based arrays for scientific or research purposes; apparatus and instruments for use in DNA, RNA, protein and polynucleic acid sequencing, namely, portable electronic sequencing devices for scientific and research use; apparatus and instruments for analysis of genetic information, genomic information and proteomic information, namely, portable electronic devices for analyzing the results of scientific tests and experiments; Silicon chips; DNA chips; Microarray chips; Analyte detector chips for scientific or research use; biosensor chips for scientific or research use; Laboratory equipment, namely, empty cartridges for use with concentrates and solutions in solid or liquid form samples for use in biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis; Nanopore sensing devices for scientific research and scientific testing use; scientific, optical, measuring and monitoring apparatus and instruments, namely, cell sorting apparatus; fluidic devices, namely, channels, reactors, columns, filters and mixers for laboratory use with nano and micro fluidic mixing; Scientific apparatus and instruments for DNA manipulation and translocation, not for medical purposes; scientific apparatus and instruments for the detection and extraction of biomolecules, namely, genetic materials, not for medical purposes; structural and component parts and fittings for all the aforesaid goods | ACTIVE | — |
| 010 | Medical and veterinary diagnostic apparatus for the testing and analysis of DNA, RNA and other genetic material for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; medical devices, namely, portable and hand-held devices for measuring, monitoring, sampling, analyzing, and delivering microarray and sequencing diagnostics; portable medical and veterinary diagnostic apparatus for the testing and analysis of DNA, RNA and other genetic material for biological, chemical, biochemical, DNA, RNA, protein and molecular analysis; blood testing apparatus; diagnostic apparatus for medical purposes for detecting target molecules of interest in a sample, in particular a patient sample; medical apparatus, in particular apparatus for bioanalysis, namely, the extraction, amplification, and detection of target molecules of interest; diagnostic apparatus for veterinary purposes for detecting target molecules of interest; automatic analyzers for medical diagnosis for detecting target molecules of interest; medical apparatus and instruments, namely, for detecting target molecules of interest; medical instruments for infectious disease testing, namely, human or veterinary pathogens; medical and veterinary apparatus and instruments, namely, for processing samples, and detecting target molecules of interest; tools for veterinary diagnostics, namely, detecting target molecules of interest; reaction units containing chemical reagents, for medical purposes; nanopore sensing devices for medical purposes; apparatus and instruments for detecting, identifying, analyzing and sorting of cells for medical and veterinary applications; structural and component parts and fittings for all the aforesaid goods | ACTIVE | — |
| 042 | Software as a service (SAAS) services featuring an integrated suite of computer software programs for analyzing, storing, querying and computing biological sequence data, for use in the fields of bioinformatics and biotechnologies; Software as a service (SAAS) services featuring an integrated suite of computer software programs for providing information and advice relating to genetics, DNA screening and DNA analysis; Structural and functional analysis of genomes; Providing temporary use of on-line non-downloadable cloud computing software for use in studying, diagnosing, screening, and studying genetics and DNA; Scientific and technological services, namely, consultation, research, and design services in the field of genetic analysis; Industrial analysis and research services in the field of genetic analysis; Measurement evaluation in the field of genetic analysis; Laboratory research in the field of genetics; Structural and functional analysis of genomes; Research in the field of genetics and genetic engineering; Advisory services relating to gene therapy research; Genetic testing for scientific research purposes; DNA manipulation and translocation services for scientific and medical research purposes; scientific and technological services, namely, scientific research in the field of genetics, genetic testing, genetic screening, genotyping, sequencing and extraction of DNA; information and advice regarding all the aforesaid services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 16, 2023 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 16, 2023 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 16, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 15, 2023 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 3, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 3, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 6, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 4, 2022 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 4, 2022 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 4, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 21, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 19, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jan 19, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jan 19, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 19, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 17, 2021 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 17, 2021 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 17, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 19, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 15, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 15, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 15, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 15, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 21, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 1, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 12, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 12, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 12, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 12, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 12, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 9, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 21, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 20, 2020 | NWAP | NEW APPLICATION ENTERED | — |